LYOPHILIZED PREPARATION OF BPA AND PREPARATION METHOD
20210338588 · 2021-11-04
Inventors
- Yuanhao LIU (Nanjing, CN)
- Lamei CHEN (Nanjing, CN)
- Xiaoming WU (Nanjing, CN)
- Hongfeng JI (Nanjing, CN)
- Yajing LI (Nanjing, CN)
- Jing HE (Nanjing, CN)
- Dongchun WANG (Nanjing, CN)
Cpc classification
A61K41/0095
HUMAN NECESSITIES
A61K9/19
HUMAN NECESSITIES
A61K47/26
HUMAN NECESSITIES
International classification
Abstract
A method for preparing a lyophilized preparation of BPA includes a solution preparation process and a freeze-drying process, where the solution preparation process includes: (1) dissolving BPA and polyol in an aqueous solution by using a base to obtain a clear solution; (2) regulating the clear solution back to 7.5<pH≤8.5 by using an acid, to obtain a BPA solution; and the freeze-drying process includes: (3) subpackaging the BPA solution and freeze-drying under a condition with a vacuum of 10-20 Pa, to obtain the lyophilized preparation. The lyophilized preparation of BPA prepared through the method has good stability and a small content of impurities.
Claims
1. A method for preparing a lyophilized preparation of 4-Boronophenylalanine (BPA), comprising a solution preparation process and a freeze-drying process, wherein the solution preparation process includes: (1) dissolving the BPA and polyol in an aqueous solution by using a base to obtain a clear solution; (2) regulating the clear solution back to 7.5<pH≤8.5 by using an acid, to obtain a BPA solution; and the freeze-drying process comprises: (3) subpackaging and freeze-drying the BPA solution under a condition with a vacuum of 10-20 Pa, to obtain the lyophilized preparation.
2. The method according to claim 1, wherein a temperature of each of the aqueous solution, the clear solution and the BPA solution in the solution preparation process is controlled to be lower than or equal to 60° C.
3. The method according to claim 1, wherein a ratio of parts by weight the BPA to the polyol is 1:1-1.3.
4. The method according to claim 1, wherein the base comprises: lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide.
5. The method according to claim 1, wherein in the solution preparation process, the BPA and the polyol are dissolved in the aqueous solution by using the base to obtain the clear solution, and a pH value of the clear solution is 8.5-9.5.
6. The method according to claim 1, wherein the polyol comprises: fructose, lactose, sorbitol, maltose, mannitol, xylitol, ribose, glucose, and sucrose.
7. The method according to claim 1, wherein after the solution preparation process, and before the freeze-drying process, the method further comprises filtering the BPA solution in a filtering step.
8. The method according to claim 1, wherein a time of the freeze-drying process is 39-80 hours.
9. The method according to claim 1, wherein the vacuum of the freeze-drying is 10-11 Pa.
10. The method according to claim 1, wherein the freeze-drying process further comprises: pre-freezing the BPA solution in a pre-freezing process, wherein a temperature of the pre-freezing process is −20° C. to −60° C.; and/or subliming the BPA solution in a sublimation process, wherein a temperature of the sublimation process is −15° C. to −35° C.; and/or desorption drying the BPA solution in a desorption drying process, wherein a temperature of the desorption drying process is 0° C. to 40° C.
11. The method according to claim 1, wherein the freeze-drying process further comprises: pre-freezing the BPA solution in a pre-freezing process, wherein a time of the pre-freezing process is 5-15 hours; and/or subliming the BPA solution in a sublimation process, wherein a time of the sublimation process is 30-55 hours; and/or desorption drying the BPA solution in a desorption drying process, wherein a time of the desorption drying process is 4-10 hours.
12. The method according to claim 1, wherein a chemical formula of the BPA is: ##STR00003## wherein B in the formula is 10B.
13. A lyophilized preparation of BPA prepared by using the method according to claim 1.
14. A composition, comprising the lyophilized preparation of BPA according to claim 13.
15. A kit, comprising the lyophilized preparation of BPA according to claim 13.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0026] The accompanying drawings illustrate one or more embodiments of the disclosure and together with the written description, serve to explain the principles of the disclosure. Wherever possible, the same reference numbers are used throughout the drawings to refer to the same or like elements of an embodiment.
[0027]
DETAILED DESCRIPTION OF THE DISCLOSURE
[0028] Unless otherwise defined, all technical and scientific terms in this specification have the same meanings as that usually understood by a person skilled in the art to which the claimed subject belongs. Unless otherwise specified, all patents, patent applications, and publications cited in this specification are incorporated herein by reference in their entirety.
[0029] It should be understood that the above brief description and the following detailed description are exemplary and only used for explanation, and are not intended to limit the subject of the present invention. In this application, unless otherwise specified, the plural forms are included when the singular form is used. It should be noted that, unless otherwise clearly specified in this specification, the singular form used in this specification and claims includes the plural referents. It is also noted that, unless otherwise specified, the use of “or”, “alternatively” means “and/or”. In addition, the terms “comprise”, “include”, and other grammatical forms such as “comprising” and “including” are not limiting. Section titles in this specification are only used for the purpose of organizing the text, and should not be explained as limitations to the subject. All documents or parts of a document cited in this application, including but not limited to patents, patent applications, articles, books, operating manuals, and papers, are incorporated herein by reference in their entirety.
[0030] The “base” described in the present invention is mainly inorganic base, including, but not limited to, lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide, and magnesium hydroxide. The “acid” described in the present invention includes inorganic acid and organic acid. The inorganic acid, for example, includes, but is not limited to, perchloric acid, hydroiodic acid, sulfuric acid, hydrobromic acid, hydrochloric acid, nitric acid, iodic acid, oxalic acid (oxalic acid), sulfurous acid, phosphoric acid, pyruvic acid, carbonic acid, citric acid, hydrofluoric acid, malic acid, gluconic acid, formic acid, lactic acid, benzoic acid, acrylic acid, ethylic acid (acetic acid), propionic acid, stearic acid, hydrosulfuric acid, hypochlorous acid, boric acid, trifluoroacetic acid, methanesulfonic acid, benzenesulfonic acid. The preferred acid is hydrochloric acid.
[0031] The “BPA” described in the present invention is 4-dihydroxyboryl phenylalanine, of which a chemical formula is
##STR00001##
where B includes .sup.10B and .sup.11B. When being .sup.10B, B may be used as a drug for the BNCT, and includes two isomers, respectively,
##STR00002##
Both configurations should be included in the scope of protection of the present invention, and the BPA of the present invention is preferably L-BPA.
[0032] Method for Preparing a Lyophilized Preparation of BPA
[0033] The present invention provides a method for preparing a lyophilized preparation of BPA, including a solution preparation process and a freeze-drying process, where the solution preparation process includes: (1) dissolving BPA and polyol in an aqueous solution by using a base to obtain a clear solution; (2) regulating the clear solution back to 7.5<pH≤8.5 by using an acid, to obtain a BPA solution; and the freeze-drying process includes: (3) subpackaging the BPA solution and freeze-drying under a condition with a vacuum of 10-20 Pa, to obtain the lyophilized preparation. To ensure that chemical properties of components in the solution do not change, in the solution preparation process, the temperature of the solution is controlled to be lower than or equal to 60° C. The “solution” mentioned herein refers to any of the “solutions” in the solution preparation process. Preferably, the temperature is 18 to 50° C., and more preferably, 18 to 40° C.
[0034] A ratio of parts by weight of the BPA to polyol affect dissolution of the BPA, but the ratio of parts by weight is not specially limited. Preferably, a ratio of parts by weight the BPA to the polyol is 1:1-1.3, preferably, 1:1.1-1.25. The polyol includes: fructose, lactose, sorbitol, maltose, mannitol, xylitol, ribose, glucose, and sucrose.
[0035] In the solution preparation process, the BPA and the polyol are dissolved in the aqueous solution by using the base, to obtain a clear solution, and a pH value of the clear solution is 8.5-9.5. Further, the clear solution needs to be regulated back to a pH value of 7.6-8.1, to obtain a BPA solution.
[0036] In the freeze-drying process, a vacuum of the freeze-drying is 10-20 Pa, preferably, 10-11 Pa. A time of the freeze-drying process is 39-80 hours. During actual operation, the above may be determined according to actual parameters in the solution preparation process, and are not specially limited. The freeze-drying process includes: a pre-freezing process, a sublimation process, and a desorption drying process. Parameters, such as a temperature, a time, and a vacuum, in the three processes may be independently selected according to actual needs. In a preferred solution, the BPA solution is freeze-dried according to the following conditions, to obtain a lyophilized preparation of BPA: in a pre-freezing process: reducing the temperature of a sample to −20° C. to −60° C., and maintaining for 5-15 hours to completely freeze the sample; in a sublimation process: raising the temperature to −15° C. to −35° C., maintaining a vacuum of 10-11 Pa, and maintaining for 30-55 hours; and in a desorption drying process: heating a partition plate to raise the temperature to 0° C. to 40° C., maintaining for 4-10 hours, and maintaining a vacuum of 10-11 Pa in the entire desorption drying process. In a preferred solution, in the pre-freezing process, the temperature sometimes may be regulated a plurality of times according to actual needs, for example, is first reduced to −60° C., and maintained for a period of time, and then, is raised to −20 to −50° C. In a preferred solution, in the desorption drying process, the temperature may be first raised to a relatively low temperature, and then be gradually raised to a relatively high temperature, for example, the temperature is first raised to 0° C. and maintained for a period of time, and then, is raised to 30±10° C.
[0037] Mainly Advantages of the Present Invention Include: [0038] 1. In the freeze-drying process, optimized process parameters are used, to greatly prevent incomplete removal of moisture in the freeze-drying process and poor temperature control from exerting adverse impact on the product form, and control the moisture of the product to the lowest level. In addition, the temperature transfer is uniform, the product is puffy and full, and has uniform particles, and phenomena, such as collapse, bubbles, looseness, and shrinkage, may not occur. [0039] 2. The product has good resolubility, quick dissolution with water, high purity, and good stability. [0040] 3. The product has no visible foreign matter, a low content of related substances, and a good impurity control effect.
[0041] Through wide and thorough researches, the inventor developed a lyophilized preparation of BPA and a preparation method, including a solution preparation process and a freeze-drying process. In the freeze-drying process, optimized process parameters are used, to greatly prevent incomplete removal of moisture in the freeze-drying process and poor temperature control from exerting adverse impact on the product form, so that preparation has good stability and a low content of impurities. The present invention is made on such basis.
[0042] The following further describes the present invention with reference to the specific embodiments. It should be understood that the following descriptions are only optimal implementations of the present invention, and should not be regarded as limitations to the protection scope of the present invention. On the basis of a full understanding of the present invention, the experimental methods without specific conditions in the following embodiments are usually in accordance with the conventional conditions or in accordance with the conditions recommended by the manufacturer. A person skilled in the art may make non-essential changes to the technical solutions of the present invention, and such changes should be included in the protection scope of the present invention. Unless otherwise specified, the percentage and the parts are the percentage by weight and the parts by weight respectively.
Embodiment 1: Preparation of a BPA Solution
[0043] (1) Add 1.0 kg of BPA, 1.1-1.3 kg of fructose, and an appropriate amount of water for injection into a solution preparation tank, wash containers containing the BPA and the fructose with water 3 times, and transfer the water used for washing into the solution preparation tank, and stir for 10 min.
[0044] (2) Add a sodium hydroxide solution into the solution preparation tank to dissolve the BPA, and stir until the solution is clear.
[0045] (3) Add a hydrochloric acid solution, to regulate a pH value of the solution to 7.6.
[0046] Whether the solution after being regulated back and prepared by using the hydrochloric acid is examined. The hydrochloric acid is added into the solution, to regulate the solution to a different pH value close to the physiological pH value. Experiment results indicating whether precipitates are generated in the solution under the condition of pH=7.3-8.5 within 48 hours are observed, as shown in Table 1. In addition, the pH values under the conditions of pH=7.6, 8.0, and 8.5 respectively are shown in Table 2, and the pH value of the solution does not change significantly within 24 hours.
TABLE-US-00001 TABLE 1 Precipitation statuses of the solution under different pH conditions within 48 hours Whether the solution pH value precipitates within 48 h 8.5 No 8.4 No 8.3 No 8.2 No 8.1 No 8.0 No 7.9 No 7.8 No 7.7 No 7.6 No 7.5 No 7.4 Yes 7.30 Yes
TABLE-US-00002 TABLE 2 pH value changes of the solution under different pH conditions within 24 hours pH Standing time at room pH value after value temperature 24 hours Characteristic 7.6 0 h 7.49 Colorless and clear 5 h 7.57 Colorless and clear 10 h 7.63 Colorless and clear 15 h 7.46 Colorless and clear 24 h 7.53 Colorless and clear 8.0 0 h 8.10 Colorless and clear 4 h 8.10 Colorless and clear 16 h 8.09 Colorless and clear 24 h 8.08 Colorless and clear 8.5 0 h 8.5 Colorless and clear 4 h 8.5 Colorless and clear 8 h 8.5 Colorless and clear 12 h 8.5 Colorless and clear 24 h 8.5 Colorless and clear
Embodiment 2
[0047] The BPA solution is freeze-dried according to the following conditions, to obtain a lyophilized preparation of BPA: [0048] (1) In a pre-freezing process: Reduce the temperature of a sample to −20° C. to −60° C., and maintain for 5-15 hours, to completely freeze the sample. [0049] (2) In a sublimation process: Raise the temperature to −15° C. to −35° C., maintain a vacuum of 10-11 Pa, and maintain for 30-55 hours. [0050] (3) In a desorption drying process: Heat a partition plate to raise the temperature to 0° C. to 40° C., maintain for 4-10 hours, and maintain a vacuum of 10-11 Pa in the entire desorption drying process.
[0051] As shown in Table 3, the lyophilized sample is redissolved with water to prepare a solution, the solution stands at room temperature for 24 hours, and none of measurement results of the pH value, the clarity, the transmittance, and the content significantly changes. After the present product is prepared and then, stands at room temperature for 24 hours, the solution has good stability.
TABLE-US-00003 TABLE 3 Stability of the solution after the lyophilized sample is redissolved Time Transmittance Content (%) of point (h) pH Clarity (%) impurities 0 8.1 Clear 99.5 0.24 4 8.0 Clear 99.4 — 8 8.1 Clear 99.4 0.26 12 8.0 Clear 99.3 — 24 8.0 Clear 99.3 0.26 30 — Precipitated — —
Embodiment 3
[0052] As shown in
[0053] The process is described in detail as follows.
[0054] {circle around (1)} Preparation procedure: adding water for injection into a solution preparation tank, adding prescription doses of BPA and an excipient, adding a sodium hydroxide solution, washing containers containing the excipient and the sodium hydroxide solution respectively with water for injection, and transferring the water used for washing to the solution preparation tank; stirring until the solution is clear; and regulating the pH value, adding the remaining water for injection, stirring evenly, detecting an intermediate, and filtering, where the excipient is the polyol described in the present invention.
[0055] {circle around (2)} Filling procedure: regulating a filling volume according to a content of the intermediate, filling, partially adding stoppers, and feeding into a freeze-drying box.
[0056] {circle around (3)} Freeze-drying procedure: including: a pre-freezing stage, a sublimation stage, and a desorption drying stage.
[0057] {circle around (4)} Unboxing and capping procedure: unboxing: protecting semi-finished products under a 100-level laminar flow, and removing and scrapping an unqualified product that, for example, lacks a stopper, has a displaced stopper, or has a broken bottle; and capping: sampling before, during, and after production to detect appearances of samples.
[0058] {circle around (5)} Packaging procedure: labeling, boxing, encasing, and storing.
[0059] Although the illustrative embodiments of the present invention have been described above in order to enable those skilled in the art to understand the present invention, it should be understood that the present invention is not to be limited the scope of the embodiments. For those skilled in the art, as long as various changes are within the spirit and scope as defined in the present invention and the appended claims, these changes are obvious and within the scope of protection claimed by the present invention.